This proposal has as its central objective, the isolation and characterization of genes that are specifically expressed in primitive reconstituting murine hematopoietic stem cells. Highly enriched populations of such stem cells will be purified by standard positive and negative selection procedures utilizing monoclonal antibodies and fluorescent dyes. Messenger RNA (mRNA) will be isolated from these cells and converted into complementary DNA (cDNA_) that will be used to construct cDNA libraries using modifications of amplification techniques capable of generating representative cDNA libraries from very small numbers of cells. The cDNA libraries will also be normalized to partially equalize the representation of abundant and rare transcripts. Transcripts specific for primitive hematopoietic stem cells will be identified by various display and capture methods to differentiate them from transcripts present in control cell populations such as non hematopoietic cells and more differentiated hematopoietic progenitor cells. Candidate transcripts will be purified and their structure characterized. cDNA libraries will also be prepared from populations of primitive hematopoietic progenitor cells (FDC- P1 cell line as well as primary explanted hematopoietic cells) synchronized at different stages of the cell cycle in hematopoietic stem cells will be isolated and characterized using various cDNA display and capture methods. Finally, the role of specific homeobox gene products ina the regulation of gene expression of primitive hematopoietic progenitor cells will be studied using a rapid high amplitude gene induciton system. By these methods, it is anticipated that a variety of novel gene products can be identified, including cell surface markers, receptors, transcriptions factors and other early response gene products. Such novel gene products could then be used as reagents in various strategies and techniques to obtain more highly enriched, even pure, primitive hematopoietic stem cells as well as committed progenitor cells for cellular biological studies, transplantation and gene transfer/therapy procedures.
| Dooner, Gerri J; Colvin, Gerald A; Dooner, Mark S et al. (2008) Gene expression fluctuations in murine hematopoietic stem cells with cell cycle progression. J Cell Physiol 214:786-95 |
| Colvin, Gerald A; Lambert, Jean-Francois; Dooner, Mark S et al. (2007) Murine allogeneic in vivo stem cell homing(,). J Cell Physiol 211:386-91 |
| Kieusseian, Aurelie; Chagraoui, Jalila; Kerdudo, Cecile et al. (2006) Expression of Pitx2 in stromal cells is required for normal hematopoiesis. Blood 107:492-500 |
| Aliotta, Jason M; Keaney, Patrick; Passero, Michael et al. (2006) Bone marrow production of lung cells: the impact of G-CSF, cardiotoxin, graded doses of irradiation, and subpopulation phenotype. Exp Hematol 34:230-41 |
| Zhang, Hui Z; Degar, Barbara A; Rogoulina, Svetlana et al. (2006) Hematopoiesis following disruption of the Pitx2 homeodomain gene. Exp Hematol 34:167-78 |
| Abedi, Mehrdad; Greer, Deborah A; Foster, Bethany M et al. (2005) Critical variables in the conversion of marrow cells to skeletal muscle. Blood 106:1488-94 |
| Quesenberry, Peter J; Colvin, Gerald; Abedi, Mehrdad (2005) Perspective: fundamental and clinical concepts on stem cell homing and engraftment: a journey to niches and beyond. Exp Hematol 33:9-19 |
| Quesenberry, Peter J; Colvin, Gerald A; Abedi, Mehrdad et al. (2005) The stem cell continuum. Ann N Y Acad Sci 1044:228-35 |
| D'Hondt, Lionel; McAuliffe, Christina; Damon, Jeffrey et al. (2004) Circadian variations of bone marrow engraftability. J Cell Physiol 200:63-70 |
| Colvin, G A; Lambert, J-F; Abedi, M et al. (2004) Murine marrow cellularity and the concept of stem cell competition: geographic and quantitative determinants in stem cell biology. Leukemia 18:575-83 |
Showing the most recent 10 out of 34 publications
